Open Access Rheumatology: Research and Reviews

Open Access Rheumatology: Research and Reviews is pleased to invite you to submit your research to the upcoming Article Collection “World Arthritis Day 2024.”

World Arthritis Day (WAD), recognized annually on October 12th, is a global awareness event aimed to highlight and bring awareness to the existence of rheumatic and musculoskeletal disorders (RMDs) in our daily lives. Established in 1996, WAD serves as a reminder for all to continue their vital research and to not stop educating the public about this painful yet incurable disease.

Despite the progress made in the last few decades, experts are not yet closer to discovering a cure and the prevalence of RMDs is only increasing with longer lifespans. This exponential rise has also resulted in greater adverse health outcomes in patients including a poorer quality of life, reduced physical function, increased hospitalizations, and detrimental effects on mental health. Furthermore, many patients with RMDs can also experience a secondary condition such as cancer or cardiovascular diseases and as such, it is necessary for physicians and other professionals to not only understand and help manage the patient’s conditions, but also ease the burden of diagnosis and therapy. Treating each condition in isolation will only serve to harm rather than lead to a good outcome.

In this regard, Open Access Rheumatology: Research and Reviews would like to invite authors to submit Original Research Articles, Reviews, Clinical Studies, and other manuscript types accepted by the journal on any subject area tailored towards arthritis that could add to the current knowledge. Possible topics include, but are not limited to:

• Pathology and pathophysiology of arthritis;
• Risk factors, clinical factors and diagnostic measures to improve the management of patients with arthritis;
• Approaches to pharmacological and non-pharmacological management of arthritis;
• Epidemiological and clinical studies on the prevalence and incidence of arthritis and comorbidities in arthritis.

Keywords: Arthritis; Rheumatic and Musculoskeletal Diseases; Pathology; Diagnosis; Treatment

View all published papers in this Article Collection here

About the Journal

Open Access Rheumatology: Research and Reviews is an international, peer-reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheumatology in the clinic and laboratory including the following topics:

• Pathology, pathophysiology of rheumatological diseases
• Investigation, treatment and management of rheumatological diseases
• Clinical trials and novel pharmacological approaches for the treatment of rheumatological disorders

Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

What is the advantage to you of publishing in Open Access Rheumatology Research and Reviews?

• It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
• Although Open Access Rheumatology Research and Reviews receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
• The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Open Access Rheumatology Research and Reviews has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
• Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Open Access Rheumatology Research and Reviews is indexed on PubMed Central (title abbreviation: Open Access Rheumatol). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee. Click here to go through to the Favored Author signup page.

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal scope and author submission instructions prior to submitting a manuscript. 

The deadline for submissions is 12 October 2024.

Please submit your manuscript on our website, using the promo code GQCTA for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “World Arthritis Day 2024” Collection.

Please contact Ashley Ambros with any queries and discount codes regarding this Article Collection.

Instructions for AuthorsSubmit an Article